Member Info for Bladey

Well thanks for the drop... Topped up lovely jubbly @ 1.72

Nor does ODX Timster... but they still ended up on SKY lol

I see a 2.02 close.... where do u see a 1.77p close?

Probability rapid covid-19 test is successfully released to mass demand: Moves to 99%
------- Based on the assumption we stay to be the fastest/cost effective test, and demand moves nationwide to worldwide!

- Average price per test sold (bearing in mind bulk orders may be heavily discounted): £10.00
------- The key here being a low cost effective affordable test to market to EVERYONE and not just a group select!..
------- So from poor to rich, regardless and sales route, so over the counter and online!

- Cost of manufacturing per test: £1 (or less)
------- The manufacturing aspect on a bulk scale is the cheapest aspect, and with our test on a stick..
------- This process is extremely fast and cheap and highly scaleable

- Other costs per test e.g. distribution, admin: £1.00
------- This really depends on the quantity made for distribution over the amount of workforce required to be involved

- Avacta % of profit share with Medusa19: Hard to put a figure exactly, ~30-40%

- Number of months of mass demand: Greater than 12 months!
------- Bearing in mind the cost being the cheapest on the market over accuracy
------- There won't be a single country that won't want it!
------- THAT's a BIG market to fill!

- Average # sold per month of mass demand: Greater than 20 million and could easily reach 60 Million
------- Assuming the production demands can be met!

In a stocks n share ISA... you can do what the hell you like, since it's high risk, there's no tax payable regardless of the gains you make...be it £10 or £1,000,000... the moneys yours.... And similarly if you lose the whole lot, basically the Govt. says "Tough", and you can't offset against other payable taxes!

Like I said...You can trade, day to day...hour by hour or keep as long term, under the ISA shell, the worlds your oyster!

Don't lie...there's a 10 min wait! lol

@Antha, agree.. we have a product/service that's usable in most avenues of medical diagnoses and hold the IP, considerable cost savings in diagnoses so would not be surprised that big pharmas would be sniffing OBD out!

Not worried here... there's no BS... it's a quality company and a quality share with quality research & product. Our sp base moves higher each week as sellers move on and gaps are filled with new buyers. The 27k shares bought yesterday at over the ask is an endorsement for me along with the PDMR holdings increase! DYOR

Have a goodun lads. catch most of you somewhere else.. Can see ESL having a better future..but I'm not into a longer play than I have encountered here. Genuine good luck to those still holding!

Morning all, I was expecting a lil more "oomphf" in the RNS especially in regards to business over the last few months which there defo was! Anyway..lets see how we fair today.. but maybe an exit plan for me now. GLA

Not sure, did say it was recording when the webinar was running, but god knows how lol. I'm sure will be available on YouTube very soon!

..Which I attended and it looks like they're very confident on the use of biomarkers in Covid-19 pandemic..

I especially liked the incentive of their peers being bought out by Roche for a lucrative deal, very nice to know.

You have to remember that this is akin to a product like a tampons or similar that requires retail sales, POC ..so basically use and throw away..available in quantity buys/bundles without the need for a Pharma dist. I think it's brilliant and the sales will reflect this... this could be a shelf product and not just over the counter item, which massively increases scale of sales!

No stop losses set .. as market makers can see them, i'm currently on terminal during trading hours so no point anyway.

Prob because we're not exactly producing right now, this is a medium to long play... a VERY GOOD play... but medium to long!

Nevertheless this should return to circa ~7p +/- 20% based on NAV alone

The 10-20K seller is the II offloading mate...reported delays by the hour, being managed well by the MM's... the odd occasion too much is pushed through which brings sp down a lil... but otherwise managed well. Quicker they go the better...so just letting them get on with it!

Agree Chester, I reckon they're literally just crossing the T's and dotting the I's on the finance... I never envisaged them having a problem getting the finance for a growing and lucrative concern!

PMSL... reminded me of the old smurf routine...where a smurf walking round and round a well say "52"..."52".. and another smurf walks by wondering what's going on... and walks over to the well and looks over to see what's inside.. and the 1st smurf walks around and pushes him from behind into the well...and continue's walking around but now saying "53"..."53" lol

Still holding punt 80k shares .. shell now... let it ride!

Imagine the manpower/hardware/cost vs time-loss required per one test in NYCT or any other lab based test, Now imagine the cost savings with a simple saliva based 10 min test!

That's the simplest I can break it down... and on those facts alone, it's a no-brainer!